Aztreonam pharmacokinetics in burn patients.
The pharmacokinetics of aztreonam in eight adult patients with severe burn injuries (total body surface area burn, 49% +/- 21% [mean +/- standard deviation]) were studied. The time of initiation of study following burn injury was 7.0 +/- 1.4 days. Four patients at first dose and at steady state were...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1991
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC244941/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2014982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.1.57 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|